Compounds that modulate intracellular calcium

Abstract

Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels. Also described herein are methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of SOC channel activity.

1 . A compound of Formula (I): 
       
         
           
           
               
               
           
         
       
       wherein:
 A is phenyl or benzofuran, wherein phenyl and benzofuran are each optionally substituted with at least one R; or A is phenyl substituted with two R groups on adjacent carbon atoms wherein the two R groups and the carbon atoms to which they are attached form a C 4 -C 8 cycloalkyl or C 3 -C 8 heterocycloalkyl; 
 R is selected from F, Cl, Br, I, —CN, —NO 2 , —CF 3 , —OH, —OR 3 , —OCF 3 , —C≡CH, —C≡CR 3 , C 1 -C 6 alkylenealkyne, C 1 -C 6 alkyl, C 3 -C 6 cycloalkyl, C 1 -C 6 heteroalkyl, C 1 -C 6 haloalkyl, tetrazolyl, C 2 -C 6 heterocycloalkyl, phenyl, —NHS(═O) 2 R 3 , S(═O) 2 N(R 4 ) 2 , —C(═O)CF 3 , —C(═O)NHS(═O) 2 R 3 , —S(═O) 2 NHC(═O)R 4 , N(R 4 ) 2 , —N(R 4 )C(═O)R 3 , —CO 2 R 4 , —C(═O)R 3 , —OC(═O)R 3 , —C(═O)N(R 4 ) 2 , —SR 3 , —S(═O)R 3 , and —S(═O) 2 R 3 ; 
 J is a bond, NHS(═O) 2 , S(═O) 2 N(R 4 ), —C(═O), —C(═O)NHS(═O) 2 , —S(═O) 2 NHC(═O), N(R 4 ), —N(R 4 )C(═O), —CO 2 , —C(═O), —OC(═O), —C(═O)N(R 4 ), —S, —S(═O), and —S(═O) 2 , C 1 -C 6 alkylene, C 2 -C 6 alkenylene, C 2 -C 6 alkynylene, C 1 -C 6 heteroalkylene, C 3 -C 6 cycloalkylene, or C 2 -C 6 heterocycloalkylene, wherein C 1 -C 6 alkylene, C 2 -C 6 alkenylene, C 2 -C 6 alkynylene, C 1 -C 6 heteroalkylene, C 3 -C 6 cycloalkylene, and C 2 -C 6 heterocycloalkylene is optionally substituted with at least one R; 
 R 1  is CO 2 R 2  or a carboxylic acid bioisostere, wherein R 2  is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 cycloalkyl, C 1 -C 6 haloalkyl, phenyl or benzyl; 
 Z is O, S, NH, N—CN, or CHNO 2 ; 
 X is W-L-phenyl, W-L-B, B, W-L-D, or D wherein phenyl, B, and D are each optionally substituted with at least one R; 
 W is NR 2 , O or a bond; 
 L is methylene, ethylene substituted with at least one R, C 3 -C 6 alkylene, C 2 -C 6 alkenylene, C 2 -C 6 alkynylene, C 1 -C 6 heteroalkylene, C 3 -C 6 cycloalkylene, or C 2 -C 6 heterocycloalkylene, wherein methylene, C 3 -C 6 alkylene, C 2 -C 6 alkenylene, C 2 -C 6 alkynylene, C 1 -C 6 heteroalkylene, C 3 -C 6 cycloalkylene, and C 2 -C 6 heterocycloalkylene is optionally substituted with at least one R; 
 B is selected from furan, thiophene, pyrrole, pyridine, oxazole, thiazole, imidazole, thiadiazole, isoxazole, isothiazole, pyrazole, pyridazine, pyrimidine, pyrazine, oxadiazole, thiadiazole, triazole, indole, benzoxazole, benzothiazole, benzimidazole, benzoxadiazole, benzothiadiazole, benzotriazole, pyrazolopyridine, imidazopyridine, pyrrolopyridine, pyrrolopyrimidine, indolizine, purine, furopyridine, thienopyridine, furopyrrole, furofuran, thienofuran, 1,4-dihydropyrrolopyrrole, thienopyrrole, thienothiophene, quinoline, isoquinoline, furopyrazole, thienopyrazole, and 1,6-dihydropyrrolopyrazole; 
 D is C 3 -C 10 cycloalkyl or C 2 -C 9 heterocycloalkyl; 
 each R 3  is independently selected from C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 3 -C 8 cycloalkyl, phenyl, and benzyl; 
 each R 4  is independently selected from hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 3 -C 8 cycloalkyl, phenyl, and benzyl; or 
 a pharmaceutically acceptable salt thereof. 
 
     
     
         2 . The compound of  claim 1  wherein R 1  is CO 2 H, R 4  is hydrogen, and Z is O. 
     
     
         3 . The compound of  claim 2  wherein J is a bond. 
     
     
         4 . The compound of  claim 3  wherein A is phenyl. 
     
     
         5 . The compound of  claim 4  wherein phenyl is substituted with one R. 
     
     
         6 . The compound of  claim 4  wherein phenyl is substituted with two R. 
     
     
         7 . The compound of  claim 4  wherein phenyl is substituted with three R. 
     
     
         8 . The compound of  claim 4  wherein R is selected from F, Cl, Br, I, or C 1 -C 6 alkyl. 
     
     
         9 . The compound of  claim 3  wherein A is benzofuran. 
     
     
         10 . The compound of  claim 9  wherein benzofuran is substituted with one R. 
     
     
         11 . The compound of  claim 4  wherein X is B selected from benzoxazole, benzothiazole, benzimidazole, pyrazolopyridine, imidazopyridine, benzoxadiazole, benzothiadiazole, and benzotriazole wherein B is optionally substituted with at least one R. 
     
     
         12 . The compound of  claim 11  wherein B is benzoxazole. 
     
     
         13 . The compound of  claim 11  wherein B is benzothiazole. 
     
     
         14 . The compound of  claim 11  wherein B is pyrazolopyridine. 
     
     
         15 . The compound of  claim 11  wherein B is benzothiadiazole. 
     
     
         16 . The compound of  claim 11  wherein R is selected from F, Cl, Br, I, —CN, —NO 2 , —CF 3 , —OH, —OR 3 , —OCF 3 , C 1 -C 6 alkylenealkyne, C 1 -C 6 alkyl, C 3 -C 6 cycloalkyl, C 1 -C 6 heteroalkyl, C 1 -C 6 haloalkyl, tetrazolyl, C 2 -C 6 heterocycloalkyl, and phenyl. 
     
     
         17 . The compound of  claim 16  wherein R is selected from F, Cl, Br, and I. 
     
     
         18 . A compound selected from: 
       
         
           
           
               
               
           
         
         
           
           
               
               
           
         
         
           
           
               
               
           
         
         
           
           
               
               
           
         
         
           
           
               
               
           
         
         
           
           
               
               
           
         
         
           
           
               
               
           
         
         
           
           
               
               
           
         
         
           
           
               
               
           
         
         
           
           
               
               
           
         
         
           
           
               
               
           
         
         
           
           
               
               
           
         
         
           
           
               
               
           
         
         
           
           
               
               
           
         
         
           
           
               
               
           
         
         
           
           
               
               
           
         
         
           
           
               
               
           
         
         
           
           
               
               
           
         
         
           
           
               
               
           
         
       
       or a pharmaceutically acceptable salt thereof. 
     
     
         19 . A pharmaceutical composition comprising a compound of  claim 1  and a pharmaceutically acceptable diluent, excipient, carrier or binder thereof. 
     
     
         20 .- 26 . (canceled)